Evaluation of the potential for QTc prolongation with avelumab

Vugmeyster, Y; Guzel, G; Hennessy, M; Loos, AH; Dai, HQ

Vugmeyster, Y (reprint author), EMD Serono Res & Dev Inst Inc, Clin Pharmacol, 45 Middlesex Turnpike, Billerica, MA 01821 USA.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019; 84 (5): 1017